Clinical Trial

Efficacy and Safety of DNN.31.19.026 for Ocular Hypertension or Primary Open-Angle Glaucoma

Name: Efficacy and Safety of DNN.31.19.026 for Ocular Hypertension or Primary Open-Angle Glaucoma — clinical trial record (NCT07617532)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: RENOIR

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the safety and efficacy of DNN.31.19.026 compared with Cosopt® for the treatment of ocular hypertension or primary open-angle glaucoma.

Trial Details

NCT Number	NCT07617532
Lead Sponsor	Ache Laboratorios Farmaceuticos S.A.
Conditions	Ocular Hypertension, Primary Open Angle Glaucoma
Enrollment	336 participants
Start Date	2026-06
Primary Completion	2028-03 (estimated)
Study Completion	2028-03 (estimated)
Updated on ClinicalTrials.gov	2026-06-01